oxford club posts
FeedPosted Mar 2nd 2011 1:00PM by Steven Halpern (RSS feed)
Filed under: Newsletters, Stocks to Buy, EZCORP (EZPW)
"As the old saying goes, banks are happy to make loans to anyone who can prove they don't need them," observes Alexander Green.
The editor of The Oxford Club explains, "But what do you do if you're a blue-collar worker with a checkered credit history, an uncertain unemployment picture and no high-quality collateral? These folks are turning to pawnbrokers such as EZCorp (EZPW).
"Based in Austin, EZCorp operates more than 1,000 pawnshops and payday loan storefronts in the United States, Canada and Mexico. It also has equity stakes in pawnshops in Britain and Australia.
Continue reading EZCorp (EZPW): Profits in Pawnshops
Posted Jul 19th 2010 10:30AM by Steven Halpern (RSS feed)
Filed under: International Markets, China, Newsletters, ETF Investing
"Everyone knows about China's outlandish growth in exports. That's no secret. But, almost totally under the radar, China is transforming itself from a world-class exporter into one of the world's biggest importers," says
Alexander Green.
The editor of
The Oxford Communique explains, "Indeed, we think China is presenting the biggest opportunity on the planet -- and we recommend the FTSE/Xinhua China 25 Index Fund (
FXI), which gives you a stake in 25 of China's very best blue-chip stocks Below, we review the fund and 14 reasons to remain bullish on the Chinese stock market.
Continue reading Xinhau China 25 (FXI): Investing in China's Blue Chips
Posted Dec 8th 2009 12:30PM by Steven Halpern (RSS feed)
Filed under: International Markets, Newsletters, Stocks to Buy, Obama Picks
Two growth stock specialists have turned bullish on the prospects for medical equipment maker Varian Medical Systems (VAR), despite uncertainty surrounding health care legislation.
Here's a look at the company from Louis Basenese, senior analyst with The Oxford Club, along with commentary from Mark Skousen, from his specialty service, The Turnaround Alert.
Mark Skousen suggests, "One stock that should benefit from 'ObamaCare' is Varian Medical Systems, the world's leader in radiation technology and X-ray imaging.
Continue reading X-ray gains: Experts eye Varian Medical (VAR)
Posted Nov 3rd 2009 10:40AM by Steven Halpern (RSS feed)
Filed under: Amazon.com (AMZN), Newsletters, Stocks to Buy
Two of the newsletter industry's leading growth stock advisors remain bullish on the prospects of online retailer Amazon.com (NASDAQ: AMZN), based on growth in not only online retailing but new market areas ranging from the Kindle e-reader to cloud computing.
Mike Cintolo, editor of The Cabot Top Ten Report, explains, "Amazon.com recently blew away earnings expectations." Meanwhile, Alexander Green, investment director at The Oxford Club, says, "In our view, the best lies ahead for the company." Here are their reviews.
Mike Cintolo continues, "Amazon announced that its Kindle e-book reader is now its most popular selling item, both in units and in dollars. That led to a big acceleration in revenue growth (28%, the fastest in five quarters), while earnings leaped 67%.
Continue reading Amazon (AMZN): 'The best is still ahead'
Posted Sep 25th 2009 1:00PM by Steven Halpern (RSS feed)
Filed under: Newsletters, Gilead Sciences (GILD), Stocks to Buy
"Gilead Sciences (NASDAQ: GILD), one of the world's largest biotechs, is a stock for all seasons," say growth expert Alexander Green.
The investment director for The Oxford Club explains, "It's a fine company with a solid balance sheet, a recession-proof business and excellent growth prospects."
"Gilead focuses on three main areas, including cardiovascular conditions and respiratory diseases. (Many may have taken its anti-influenza drug Tamiflu, Letairis to treat hypertension, or Macugen to treat macular degeneration.)
Continue reading Gilead (GILD): 'A stock for all seasons'
Posted Jul 24th 2009 3:20PM by Steven Halpern (RSS feed)
Filed under: International Markets, Newsletters, Diageo plc (DEO), Stocks to Buy, Recession
"Diageo (NYSE: DEO), the world's largest spirits maker, offers solid and safe dividend, as well as the potential for strong capital appreciation," says Louis Basenese.
The senior analyst for the prestigious The Oxford Club suggests, "Moreover, investors can also prepare for a US dollar decline by buying these shares." Here's his bullish outlook.
"Headquartered in London, roughly 70% of the company's sales come from outside the United States. So any dollar dip will increase the value of our ADRs.
"Moreover, management concedes that positive currency tailwinds in the other countries where Diageo sells spirits will help the company easily grow earnings by double digits this year.
Continue reading Diageo: Toast to growth & income
Posted Apr 24th 2009 10:30AM by Steven Halpern (RSS feed)
Filed under: Newsletters, ETF Investing, Agriculture, Stocks to Buy, Recession
In a difficult economic environment, it is often wise for investors to consider stocks in more defensive and relatively recession-resistant sectors. And one such area is food and beverage stocks.
As the long-standing market maxim goes, consumers can pull back on spending for vacations, remodeling, and new cars, but they still need to eat and drink.
In that light, I turned to nine leading newsletter advisors who serve up their current favorite ideas in the food and beverage sector:
Continue reading Food for thought: Best buys in food & beverage
Posted Apr 22nd 2009 11:30AM by Steven Halpern (RSS feed)
Filed under: International Markets, Newsletters, Diageo plc (DEO), Stocks to Buy, Recession
This post is part of a seven article report -- Food for thought: Best bets in food & beverage stocks..
"If you're buying stocks to meet long-term investment goals, now is an excellent time to do some bargain hunting," says Alexander Green. In The Oxford Communique he looks to Diageo (NYSE: DEO).
"One good place to start is with Diageo. We like the outlook for company, which is the world's largest spirit maker. In good times or bad, people drink. According to some studies, even more during the bad times.
"With eight of the top 20 brands, and unparalleled marketing and distribution operations, Diageo is the best way to tap into the globe's steady demand for high-quality spirits.
Continue reading Diageo (DEO): In good spirits
Posted Feb 23rd 2009 2:00PM by Steven Halpern (RSS feed)
Filed under: Newsletters, Stocks to Buy, Recession, Obama Picks
Two leading growth stock expert, Brandon Clay, editor of Invest with an Edge, and Alexander Green, editor of The Oxford Club, turn to automated blood testing equipment maker Immucor (NASDAQ: BLUD) as a recession-resistant buy.
Clay suggest, "A good bet is to go with the strongest stock in that particular sector at the time of your pickThat way, the company you select at least has the momentum of the sector backing it. Typically the medical industry performs better than the overall market in a downturn. This recession has been no different.
"As we dug deeper into health care, one company surfaced that was worth our attention. Immucor is a blood testing equipment manufacturer specializing in pre-transfusion diagnostics.
"Established in 1982, they brought their first patent to market four years later. Since then they've become a leader in blood diagnostics and blood bank technology.
Continue reading Immucor (BLUD): Two experts bank on blood bank buy
Next Page >